Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidase) in Multifocal Motor Neuropathy (MMN)
- First Posted Date
- 2015-09-22
- Last Posted Date
- 2018-05-17
- Lead Sponsor
- Johannes Jakobsen
- Target Recruit Count
- 18
- Registration Number
- NCT02556437
- Locations
- 🇩🇰
Department of Neurology, Aarhus University Hospital, Aarhus C, Denmark
🇩🇰Department of Neurology, Rigshospitalet, Copenhagen, Denmark
News
No news found